CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sector revisions Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 16/01/2026 GMT			5-day change	1st Jan Change
219.70 ^USD	-1.69%		+0.40%	+10.14%

01-16	Citigroup Adjusts Price Target on Charles River Laboratories International to $265 From $200, Maintains Buy Rating	MT
01-13	Charles River Laboratories International, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.							14
	LONZA GROUP AG							23
	IQVIA HOLDINGS INC.							20
	BEONE MEDICINES AG							24
	CELLTRION, INC.							22
	REVOLUTION MEDICINES, INC.							19
	MEDPACE HOLDINGS, INC.							12
	EUROFINS SCIENTIFIC SE							15
	ICON PUBLIC LIMITED COMPANY							16
	ASCENDIS PHARMA A/S							15
	TEMPUS AI, INC.							12
	IONIS PHARMACEUTICALS, INC.							22
	BIO-TECHNE CORPORATION							12
	QIAGEN N.V.							13
	Average							17
	Weighted average by Cap.							19

Other Biotechnology & Medical Research

Stock Market
Equities
CRL Stock
Sector Charles River Laboratories International, Inc.
Sector revisions

As early as today, start finding the best investment opportunities!